Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine and magnesium interaction study in healthy volunteers
ISRCTN18075783Phase 4Completed
- Sponsor
- University Hospital Zurich
- Start
- Dec 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of levothyroxine sodium, magnesium and Magnesium aspartate in hypothyroidism (3 arms), sponsored by University Hospital Zurich. Primary endpoint: AUC of total thyroxine. Started Dec 2023; status: completed.
02
Drugs
levothyroxine sodiummagnesiumMagnesium aspartate
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on ISRCTN18075783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN18075783.